nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AD biomarker discovery in CSF and in alternative matrices
|
Sancesario, Giulia |
|
2019 |
72 |
C |
p. 52-57 |
artikel |
2 |
Alzheimer's disease: Making the point
|
Bernardini, Sergio |
|
2019 |
72 |
C |
p. 1-2 |
artikel |
3 |
Assessment of lipid peroxidation and artificial neural network models in early Alzheimer Disease diagnosis
|
Peña-Bautista, Carmen |
|
2019 |
72 |
C |
p. 64-70 |
artikel |
4 |
Blood-based molecular signature of Alzheimer's disease via spectroscopy and metabolomics
|
Habartová, Lucie |
|
2019 |
72 |
C |
p. 58-63 |
artikel |
5 |
Clinical aspects of Alzheimer's disease
|
Zvěřová, Martina |
|
2019 |
72 |
C |
p. 3-6 |
artikel |
6 |
Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers
|
Farotti, Lucia |
|
2019 |
72 |
C |
p. 24-29 |
artikel |
7 |
Editorial Board
|
|
|
2019 |
72 |
C |
p. IFC |
artikel |
8 |
Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid
|
Lifke, Valeria |
|
2019 |
72 |
C |
p. 30-38 |
artikel |
9 |
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
|
Shaw, Leslie M. |
|
2019 |
72 |
C |
p. 7-14 |
artikel |
10 |
Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease
|
Ozben, Tomris |
|
2019 |
72 |
C |
p. 87-89 |
artikel |
11 |
New molecular approaches to Alzheimer's disease
|
Di Resta, Chiara |
|
2019 |
72 |
C |
p. 81-86 |
artikel |
12 |
Plasma amyloid beta levels and platelet mitochondrial respiration in patients with Alzheimer's disease
|
Fišar, Zdeněk |
|
2019 |
72 |
C |
p. 71-80 |
artikel |
13 |
Search for biomarkers of Alzheimer‘s disease: Recent insights, current challenges and future prospects
|
Hrubešová, Kateřina |
|
2019 |
72 |
C |
p. 39-51 |
artikel |
14 |
The standardization of cerebrospinal fluid markers and neuropathological diagnoses brings to light the frequent complexity of concomitant pathology in Alzheimer's disease: The next challenge for biochemical markers?
|
Fenouil, Tanguy |
|
2019 |
72 |
C |
p. 15-23 |
artikel |